Research Report: PAHC

Analysis Date: 2025-12-07T16:37:31.448499 Trading Period: 2025-12-08 to 2025-12-19

Company Overview

Company: Phibro Animal Health Corporation Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic Current Price: $39.16 Market Cap: $1,587,296,128 Beta: 0.77 Avg Volume: 295,618 P/E Ratio: 23.45 Website: https://www.pahc.com

Description: Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, su...

Trading Recommendation

Action: STRONG AVOID Confidence: 20.0/100 Position Size: 0.0% of portfolio

Rationale: Unfavorable conditions (composite: 3.0/100, risk: EXTREME, red flags: 2).

Key Risks:

Screening Status

Passed Filters: ✗ No Notes: Failed one or more screening filters (volume, price, market cap, etc.)

Quantitative Analysis

Composite Score: 0.00/5.0 Percentile Rank: 0%

Factor Scores:

Technical Analysis

Setup Score: 0/8 Setup Notes:

Price Levels:

Momentum & Volume:

Risk Assessment

Risk Level: EXTREME Confidence: 10.0/100 Total Red Flags: 2 Earnings Risk: No

Critical Issues:

Stock-Specific Red Flags:


This report is generated by PM automated research system. Always perform your own due diligence before trading.